Under the submission, the device company can seek FDA feedback on its planned submission of an Investigational Device Exemption. Feedback could include comment on proposed study design or statistical analysis plan.
The ReActiv8 is designed for the treatment of chronic lower back pain.
More Articles on Devices:
4 New Mazor Robotic Spine Surgery Systems Sold in Q2
10 Observations on the Global Sports Medicine Device Market
Amedica Secures $26M Funding: 5 Things to Know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
